|
1
|
DeSantis CE, Miller KD, Goding Sauer A,
Jemal A and Siegel RL: Cancer statistics for African Americans,
2019. CA Cancer J Clin. 69:211–233. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li J, Guo W, Ran J, Tang R, Lin H, Chen X,
Ning B, Li J, Zhou Y, Chen LC, et al: Five-year lung cancer
mortality risk analysis and topography in Xuan Wei: A
spatiotemporal correlation analysis. BMC Public Health. 19:1732019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barta JA, Powell CA and Wisnivesky JP:
Global epidemiology of lung cancer. Ann Glob Health. 85:82019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nedović-Vuković M, Laušević D, Ljaljević
A, Golubović M and Trajković G: Lung cancer mortality in
Montenegro, 1990 to 2015. Croat Med J. 60:26–32. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Haas K, Brillante C, Sharp L, Elzokaky AK,
Pasquinelli M, Feldman L, Kovitz KL and Joo M: Lung cancer
screening: assessment of health literacy and readability of online
educational resources. BMC Public Health. 18:13562018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oze I, Ito H, Nishino Y, Hattori M,
Nakayama T, Miyashiro I, Matsuo K and Ito Y: Trends in small-cell
lung cancer survival in 1993–2006 based on population-based cancer
registry data in Japan. J Epidemiol. 29:347–353. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Riveiro-Falkenbach E, Ruano Y,
Garcia-Martin RM, Lora D, Cifdaloz M, Acquadro F, Ballestín C,
Ortiz-Romero PL, Soengas MS and Rodríguez-Peralto JL: DEK oncogene
is overexpressed during melanoma progression. Pigment Cell Melanoma
Res. 30:194–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang Y, Gao M, Lin Z, Chen L, Jin Y, Zhu
G, Wang Y and Jin T: DEK promoted EMT and angiogenesis through
regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer.
Oncotarget. 8:98708–98722. 2017.PubMed/NCBI
|
|
9
|
Lin D, Dong X, Wang K, Wyatt AW, Crea F,
Xue H, Wang Y, Wu R, Bell RH, Haegert A, et al: Identification of
DEK as a potential therapeutic target for neuroendocrine prostate
cancer. Oncotarget. 6:1806–1820. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Waldmann T, Scholten I, Kappes F, Hu HG
and Knippers R: The DEK protein-an abundant and ubiquitous
constituent of mammalian chromatin. Gene. 343:1–9. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fu GK, Grosveld G and Markovitz DM: DEK,
an autoantigen involved in a chromosomal translocation in acute
myelogenous leukemia, binds to the HIV-2 enhancer. Proc Natl Acad
Sci USA. 94:1811–1815. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kappes F, Scholten I, Richter N, Gruss C
and Waldmann T: Functional domains of the ubiquitous chromatin
protein DEK. Mol Cell Biol. 24:6000–6010. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Matrka MC, Watanabe M, Muraleedharan R,
Lambert PF, Lane AN, Romick-Rosendale LE and Wells SI:
Overexpression of the human DEK oncogene reprograms cellular
metabolism and promotes glycolysis. PLoS One. 12:e01779522017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Böhm F, Kappes F, Scholten I, Richter N,
Matsuo H, Knippers R and Waldmann T: The SAF-box domain of
chromatin protein DEK. Nucleic Acids Res. 33:1101–1110. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kappes F, Burger K, Baack M, Fackelmayer
FO and Gruss C: Subcellular localization of the human
proto-oncogene protein DEK. J Biol Chem. 276:26317–26323. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Waldmann T, Eckerich C, Baack M and Gruss
C: The ubiquitous chromatin protein DEK alters the structure of DNA
by introducing positive supercoils. J Biol Chem. 277:24988–24994.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sandén C and Gullberg U: The DEK
oncoprotein and its emerging roles in gene regulation. Leukemia.
29:1632–1636. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu Y, Liang Z, Li C, Yang Z and Chen L:
LCMR1 interacts with DEK to suppress apoptosis in lung cancer
cells. Mol Med Rep. 16:4159–4164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boer J, Mahmoud H, Raimondi S, Grosveld G
and Krance R: Loss of the DEK-CAN fusion transcript in a child with
t(6;9) acute myeloid leukemia following chemotherapy and allogeneic
bone marrow transplantation. Leukemia. 11:299–300. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou QC, Deng XF, Yang J, Jiang H, Qiao
MX, Liu HH, Qian Z, Hou LL and Hu HG: Oncogene DEK is highly
expressed in lung cancerous tissues and positively regulates cell
proliferation as well as invasion. Oncol Lett. 15:8573–8581.
2018.PubMed/NCBI
|
|
21
|
Ou Y, Xia R, Kong F, Zhang X, Yu S, Jiang
L, Zheng L and Lin L: Overexpression of DEK is an indicator of poor
prognosis in patients with gastric adenocarcinoma. Oncol Lett.
11:1823–1828. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu X, Zou L, Yao Q, Zhang Y, Gan L and
Tang L: Silencing DEK downregulates cervical cancer tumorigenesis
and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin
axis. Oncol Rep. 38:1035–1042. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu K, Feng T, Liu J, Zhong M and Zhang S:
Silencing of the DEK gene induces apoptosis and senescence in CaSki
cervical carcinoma cells via the up-regulation of NF-κB p65. Biosci
Rep. 32:323–332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Sun L, Yang M, Luo W, Gao Y, Liu
Z, Qiu X and Wang E: DEK depletion negatively regulates
Rho/ROCK/MLC pathway in non-small cell lung cancer. J Histochem
Cytochem. 61:510–521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Lei L, Zheng YW, Zhang L, Li ZH,
Shen HY, Jiang GY, Zhang XP, Wang EH and Xu HT: Odd-skipped related
1 inhibits lung cancer proliferation and invasion by reducing Wnt
signaling through the suppression of SOX9 and β-catenin. Cancer
Sci. 109:1799–1810. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lei L, Wang Y, Zheng YW, Fei LR, Shen HY,
Li ZH, Huang WJ, Yu JH and Xu HT: Overexpression of Nemo-like
kinase promotes the proliferation and invasion of lung cancer cells
and indicates poor prognosis. Curr Cancer Drug Targets. 19:674–680.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Soekarman D, von Lindern M, van der Plas
DC, Selleri L, Bartram CR, Martiat P, Culligan D, Padua RA,
Hasper-Voogt KP, Hagemeijer A, et al: Dek-can rearrangement in
translocation (6;9)(p23;q34). Leukemia. 6:489–494. 1992.PubMed/NCBI
|
|
29
|
Capitano ML and Broxmeyer HE: A role for
intracellular and extracellular DEK in regulating hematopoiesis.
Curr Opin Hematol. 24:300–306. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sandén C, Nilsson HJ and Gullberg U: The
DEK oncoprotein is upregulated by multiple leukemia-associated
fusion genes. Blood Cells Mol Dis. 54:284–285. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Diaz-Serrano A, Gella P, Jimenez E,
Zugazagoitia J and Paz-Ares Rodriguez L: Targeting EGFR in lung
cancer: Current standards and developments. Drugs. 78:893–911.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jurišić V, Obradovic J, Pavlović S and
Djordjevic N: Epidermal growth factor receptor gene in
non-small-cell lung cancer: The importance of promoter polymorphism
investigation. Anal Cell Pathol (Amst). 2018:61921872018.PubMed/NCBI
|
|
33
|
Bernicker EH, Allen TC and Cagle PT:
Update on emerging biomarkers in lung cancer. J Thorac Dis. 11
(Suppl 1):S81–S88. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
van Neerven SM and Vermeulen L: The
interplay between intrinsic and extrinsic Wnt signaling in
controlling intestinal transformation. Differentiation. 108:17–23.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schaefer KN and Peifer M: Wnt/Beta-catenin
signaling regulation and a role for biomolecular condensates. Dev
Cell. 48:429–444. 2019. View Article : Google Scholar : PubMed/NCBI
|
